XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 2,225 $ 2,165
Accounts receivables, net of allowance for credit losses of $94 million and $90 million as of September 30, 2022 and December 31, 2021 3,730 4,529
Inventories 3,859 3,818
Prepaid expenses 1,045 1,075
Other current assets 579 965
Assets held for sale 16 19
Total current assets 11,453 12,573
Deferred income taxes 1,546 596
Other non-current assets 438 515
Property, plant and equipment, net 5,568 5,982
Operating lease right-of-use assets 422 495
Identifiable intangible assets, net 6,393 7,466
Goodwill [1] 18,433 20,040
Total assets 44,252 47,666
Current liabilities:    
Short-term debt 2,769 1,426
Sales reserves and allowances 3,648 4,241
Accounts payables 1,635 1,686
Employee-related obligations 496 563
Accrued expenses 2,041 2,208
Other current liabilities 945 903
Total current liabilities 11,534 11,027
Long-term liabilities:    
Deferred income taxes 503 784
Other taxes and long-term liabilities 3,846 2,578
Senior notes and loans 18,497 21,617
Operating lease liabilities 354 416
Total long-term liabilities 23,200 25,395
Commitments and contingencies, see note 10
Total liabilities 34,734 36,422
Teva shareholders' equity:    
Ordinary shares of NIS 0.10 par value per share; September 30, 2022 and December 31, 2021: authorized 2,495 million shares; issued 1,216 million shares and 1,209 million shares, respectively. 57 57
Additional paid-in capital 27,652 27,561
Accumulated deficit (11,660) (10,529)
Accumulated other comprehensive loss (3,153) (2,683)
Treasury shares as of September 30, 2022 and December 31, 2021: 106 million ordinary shares (4,128) (4,128)
Stockholders' equity attributable to Teva shareholders 8,767 10,278
Non-controlling interests 751 966
Total equity 9,519 11,244
Total liabilities and equity $ 44,252 $ 47,666
[1] Accumulated goodwill impairment as of September 30, 2022 and December 31, 2021 was approximately $26.3 billion and $25.6 billion, respectively.